New combo therapy shows promise for resistant depression
NCT ID NCT06431386
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested whether adding a type of talk therapy (behavioral activation) to esketamine treatment helps people with depression that hasn't improved with other treatments. Six adults with major depression or bipolar disorder took part. The goal was to see if practicing new behaviors while feeling better from esketamine leads to longer-lasting mood improvement.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BIPOLAR DISORDER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
The Royal Ottawa Mental Health Centre
Ottawa, Ontario, K1Z 7K4, Canada
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a single dose of a new drug boost depression relief?
- One-Day brain zaps: a new hope for stubborn depression?
- Can a web app get people moving in mental health residential care?
- Can a new pill ease depression without Add-Ons?
- Smartwatch data may forecast bipolar mood swings
- Could a talking therapy ease the weight of bipolar depression?